Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Neurocrine Biosciences Inc (NBIX)

  • SEC News
  • Jan. 21, 2026, 13:18 UTC
  • 3
  • 0 comments

New Form SCHEDULE 13G - NEUROCRINE BIOSCIENCES INC Filed: 2026-01-21 AccNo: 0000019617-26-000046 Size: 6 KB

Comment Full text

Foxo Technologies Inc (FOXO)

  • SEC News
  • Jan. 21, 2026, 13:06 UTC
  • 2
  • 0 comments

New Form SCHEDULE 13G - FOXO TECHNOLOGIES INC. Filed: 2026-01-21 AccNo: 0001535610-26-000014 Size: 9 KB

Comment Full text

Applied Therapeutics (APLT)

  • SEC News
  • Jan. 21, 2026, 13:06 UTC
  • 3
  • 0 comments

New Form SC TO-T/A - Applied Therapeutics, Inc. Filed: 2026-01-21 AccNo: 0001193125-26-017254 Size: 42 KB

Comment Full text

Baxter International Inc (BAX)

  • SEC News
  • Jan. 21, 2026, 13:06 UTC
  • 2
  • 0 comments

New Form SCHEDULE 13G/A - BAXTER INTERNATIONAL INC Filed: 2026-01-21 AccNo: 0001027796-26-000005 Size: 7 KB

Comment Full text

Portage Biotech Inc. (PRTG)

  • SEC News
  • Jan. 21, 2026, 11:17 UTC
  • 3
  • 0 comments

New Form 6-K/A - AlphaTON Capital Corp Filed: 2026-01-21 AccNo: 0001171843-26-000354 Size: 6 MB

Comment Full text

Daxor Corporation (DXR)

  • SEC News
  • Jan. 21, 2026, 11:05 UTC
  • 3
  • 0 comments

New Form EFFECT - DAXOR CORP Filed: 2026-01-20 AccNo: 9999999995-26-000211 Size: 1 KB

Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • SEC News
  • Jan. 21, 2026, 11:05 UTC
  • 3
  • 0 comments

New Form EFFECT - Avalo Therapeutics, Inc. Filed: 2026-01-20 AccNo: 9999999995-26-000222 Size: 1 KB

Comment Full text

Medi Lifestyle Limited (Z4D)

  • SEC News
  • Jan. 21, 2026, 10:41 UTC
  • 3
  • 0 comments

General Announcement: Minutes of Extraordinary General Meeting held on 22 December 2025

Comment Full text

Haw Par Corporation Limited (H02)

  • SEC News
  • Jan. 21, 2026, 09:29 UTC
  • 4
  • 0 comments

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/ Changes in Interest of Substantial Shareholder

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • Jan. 21, 2026, 09:28 UTC
  • 4
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text
  • Previous
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187797)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124243)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin